Sweden's Lumito posts first commercial sales, Q1 net loss narrows

Lumito AB (publ)

07/05/2026 07:40

Overview

Sweden medical imaging firm's Q1 net sales reached 78 KSEK, marking initial commercial revenue

Q1 net loss narrowed year-over-year as operating costs declined post-development phase

Company secured initial customer orders and launched multiple pilot projects during the quarter

Outlook

Lumito says it will focus on converting collaborations into long-term business and commercial scaling

Result Drivers

INITIAL CUSTOMER ORDERS - Company said first net sales were driven by initial and recurring orders for SCIZYS Erbium kits, marking transition to commercial use

SCAN-AS-A-SERVICE MODEL - CEO said Scan-as-a-Service offering enabled low-barrier adoption and supports recurring and scalable revenue streams

PARTNERSHIPS AND PILOT PROJECTS - Strategic partnerships and pilot collaborations cited as validating technology and expanding commercial opportunities

Company press release: ID:nMFN9B22Mv

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 78,000
Q1 Adjusted EPS
-SEK 3.05
Q1 Cash flow from operating activities
-SEK 6.73 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)